165 related articles for article (PubMed ID: 2033679)
1. Serum ferritin: a tumor marker for renal cell carcinoma.
Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
[TBL] [Abstract][Full Text] [Related]
2. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
[TBL] [Abstract][Full Text] [Related]
4. [Serum ferritin determination: is it useful in the early diagnosis of renal carcinoma?].
D'Addessi A; Racioppi M; Zappacosta B; Fanasca A; De Michele T; Alcini E
Arch Ital Urol Androl; 1997 Dec; 69(5):283-6. PubMed ID: 9477611
[TBL] [Abstract][Full Text] [Related]
5. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Hayashi T; Kanetake H
BJU Int; 2001 Dec; 88(9):974-7. PubMed ID: 11851623
[TBL] [Abstract][Full Text] [Related]
7. Ferritin: a tumor marker expressed by renal cell carcinoma.
Kirkali Z; Esen AA; Kirkali G; Güner G
Eur Urol; 1995; 28(2):131-4. PubMed ID: 8529738
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum ferritin in patients with renal cell carcinoma.
Ozen H; Uygur C; Sahin A; Tekgül S; Ergen A; Remzi D
Urology; 1995 Oct; 46(4):494-8. PubMed ID: 7571217
[TBL] [Abstract][Full Text] [Related]
9. Tumour-associated trypsin inhibitor and renal cell carcinoma.
Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
[TBL] [Abstract][Full Text] [Related]
10. Serum immunosuppressive acidic protein in renal cell carcinoma.
Ueda T
Urol Res; 1986; 14(2):101-3. PubMed ID: 3727211
[TBL] [Abstract][Full Text] [Related]
11. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
[TBL] [Abstract][Full Text] [Related]
12. Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
Fujikawa K; Matsui Y; Miura K; Kobayashi T; Oka H; Fukuzawa S; Takeuchi H
J Urol; 2000 Sep; 164(3 Pt 1):673-5. PubMed ID: 10953123
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma.
Fujimoto K; Ichimori Y; Yamaguchi H; Arai K; Futami T; Ozono S; Hirao Y; Kakizoe T; Terada M; Okajima E
Jpn J Cancer Res; 1995 Feb; 86(2):182-6. PubMed ID: 7730142
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
Takashi M; Haimoto H; Tanaka J; Murase T; Kato K
J Urol; 1989 Apr; 141(4):830-4. PubMed ID: 2648028
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of serum levels of CEA, CA 50, and ferritin in the management of renal cell cancer.
Kokociñska D; Rajchel K; Nalewajka E; Zagalski K
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):279-81. PubMed ID: 9216822
[TBL] [Abstract][Full Text] [Related]
16. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
[TBL] [Abstract][Full Text] [Related]
17. Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer?
Uzzo RG
J Urol; 2008 Aug; 180(2):433-4. PubMed ID: 18550098
[No Abstract] [Full Text] [Related]
18. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.
Sato K; Tsuchiya N; Sasaki R; Shimoda N; Satoh S; Ogawa O; Kato T
Jpn J Cancer Res; 1999 Aug; 90(8):874-9. PubMed ID: 10543260
[TBL] [Abstract][Full Text] [Related]
19. The Significance of Pregnancy-associated Plasma Protein a Serum Concentration in Clear Cell Renal Cell Carcinoma.
Cechova M; Chocholaty M; Zima T; Babjuk M; Kalousova M
Anticancer Res; 2019 Jun; 39(6):3249-3253. PubMed ID: 31177175
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide-specific antigen in renal cell carcinoma.
Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
